The Value of Intellectual Property
Even before a drug or medical device reaches blockbuster status, protecting intellectual property should still be a priority.
Even before a drug or medical device reaches blockbuster status, protecting intellectual property should still be a priority.
Less than 15 percent of unsolicited inquiries to Big Pharma actually get reviewed.
How can a pharmaceutical startup grab the attention of Big Pharma?
OneMedPlace announced that the leading Universities and Hospitals in the New York area will showcase their most promising medical technologies June 30th at the OneMedForum NY 2010 in Midtown Manhattan.
Paul Chaney, President of PanOptica, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Robin Stracey, President and CEO of Cantimer, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Below are some updates and developments from the past week.
Over 100 companies and 500 investors are expected to attend the OneMedPlace Finance Forum, to take place from January 12-14 in San Francisco.
OneMedPlace has entered into a partnership with Marketwire, a full-service newswire and communications workflow solutions provider for public relations, investor relations and marketing communications professionals, to accomplish the company’s media outreach goals.
Copyright © 2024 | WordPress Theme by MH Themes